Preoperative RAAS Blockade Does Not Associate With Vasoplegia After Cardiopulmonary Bypass

INTRODUCTION: Postcardiotomy vasoplegia affects ∼20% of cardiopulmonary bypass (CPB) patients and associates with acute kidney failure, prolonged hospital stay, and mortality. Preliminary work revealed that nonvasoplegic CPB patients exhibit an immediate and robust increase in renin and Angiotensin II (Ang II), while vasoplegic patients exhibit a blunted renin and Ang II response. As many cardiac surgery patients are receiving renin-angiotensin-aldosterone (RAAS)-modifying medications preoperatively, this cohort study investigated if preoperative use of RAAS-inhibiting medications is associated with CPB-associated vasoplegia. METHODS: Sixty-six elective CPB patients at our tertiary referral center were prospectively enrolled and categorized as vasoplegic or nonvasoplegic based on immediate postoperative vasopressor requirements and cardiac index. Rates of preoperative medication use between nonvasoplegic and vasoplegic patients were compared: ACE inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), beta-adrenergic blockers, ARB-neprilysin inhibitors (ARNI), statins and mixed polypharmacy groups were evaluated. RESULTS: Forty-nine patients were non-vasoplegic controls compared to 17 vasoplegic patients. All three patients on ARNI preoperatively became vasoplegic (3/17 (17.6%), versus 0/49 nonvasoplegic (0%), P = 0.015). For all other groups - patients on a beta blocker, ACEI, ARB, statin, or any combination of these medications - rates of pre-operative medication did not associate significantly with vasoplegia status. CONCLUSIONS: The use and timing of discontinuation of pre-operative beta-adrenergic blocker, ACEI, ARB, and statin did not correlate with the incidence of post-operative vasoplegia. The use of ARNIs was positively associated with vasoplegia in a limited sample size. As a result, we believe post-CPB vasoplegia may have a separate pathway from preoperative RAAS modulators that requires further investigation.

Authors

Institutions

Publication Details

Journal
Journal of Surgical Research
Published
2026-11-18
DOI
https://doi.org/10.1016/j.jss.2026.10.042
Primary Topic
Cardiac and Coronary Surgery Techniques
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Preoperative RAAS Blockade Does Not Associate With Vasoplegia After Cardiopulmonary Bypass

Benjamin I. Schachner, Bartlomiej R. Imielski, Mark Cordell, Christopher L. Schaich et al.
2 links
Journal of Surgical Research
Cardiac and Coronary Surgery Techniques
article

Preoperative RAAS Blockade Does Not Associate With Vasoplegia After Cardiopulmonary Bypass

Benjamin I. Schachner, Bartlomiej R. Imielski, Mark Cordell, Christopher L. Schaich, Mark C. Chappell, Ashish Kumar Khanna, Spencer Tingey, Paige Behr, Jorge Seoane, Jake duPlooy
article en

Abstract

INTRODUCTION: Postcardiotomy vasoplegia affects ∼20% of cardiopulmonary bypass (CPB) patients and associates with acute kidney failure, prolonged hospital stay, and mortality. Preliminary work revealed that nonvasoplegic CPB patients exhibit an immediate and robust increase in renin and Angiotensin II (Ang II), while vasoplegic patients exhibit a blunted renin and Ang II response. As many cardiac surgery patients are receiving renin-angiotensin-aldosterone (RAAS)-modifying medications preoperatively, this cohort study investigated if preoperative use of RAAS-inhibiting medications is associated with CPB-associated vasoplegia. METHODS: Sixty-six elective CPB patients at our tertiary referral center were prospectively enrolled and categorized as vasoplegic or nonvasoplegic based on immediate postoperative vasopressor requirements and cardiac index. Rates of preoperative medication use between nonvasoplegic and vasoplegic patients were compared: ACE inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), beta-adrenergic blockers, ARB-neprilysin inhibitors (ARNI), statins and mixed polypharmacy groups were evaluated. RESULTS: Forty-nine patients were non-vasoplegic controls compared to 17 vasoplegic patients. All three patients on ARNI preoperatively became vasoplegic (3/17 (17.6%), versus 0/49 nonvasoplegic (0%), P = 0.015). For all other groups - patients on a beta blocker, ACEI, ARB, statin, or any combination of these medications - rates of pre-operative medication did not associate significantly with vasoplegia status. CONCLUSIONS: The use and timing of discontinuation of pre-operative beta-adrenergic blocker, ACEI, ARB, and statin did not correlate with the incidence of post-operative vasoplegia. The use of ARNIs was positively associated with vasoplegia in a limited sample size. As a result, we believe post-CPB vasoplegia may have a separate pathway from preoperative RAAS modulators that requires further investigation.

Journal of Surgical ResearchVol. 328
Atrium Health Wake Forest Baptist (US), Outcomes Research Consortium (US), Wake Forest University Health Sciences (US), Wake Forest University (US)
National Institutes of Health, Wake Forest Clinical and Translational Science Institute, Wake Forest School of Medicine
Good health and well-being
Cardiac and Coronary Surgery Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon